798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL): a trial of the European Working Group for Adult ALL (EWALL-PH-02)

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Ottmann, Oliver G. (BerichterstatterIn) , Heidenreich, Daniela (BerichterstatterIn)
Dokumenttyp: Article (Journal) Konferenzschrift
Sprache:Englisch
Veröffentlicht: 2014
In: Blood
Year: 2014, Jahrgang: 124, Heft: 21
ISSN:1528-0020
Schlagworte:
Online-Zugang:Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0006497119697375
Volltext
Verfasserangaben:Oliver G. Ottmann, Heike Pfeifer, Jean-Michel Cayuela, Karsten Spiekermann, Joachim Beck, Wolfram E Jung, Andreas Viardot, Schäfer-Eckart Kerstin, Albrecht Reichle, Sébastien Maury, Norbert Schmitz, Daniela Heidenreich, Jens Panse, Christian Junghanß, Emmanuel Raffoux, Felipe Suarez, Gäelle Guillerm, Magda Alexis, Severine Lissandre, Françoise Huguet, Françoise Isnard, Stephane Lepretre, Martine Escoffre-Barbe, Josep-Maria Ribera, Nicola Goekbuget, Herve Dombret, Dieter Hoelzer, Philippe Rousselot

MARC

LEADER 00000caa a2200000 c 4500
001 1505167191
003 DE-627
005 20241002090454.0
007 cr uuu---uuuuu
008 150707s2014 xx |||||o 00| ||eng c
035 |a (DE-627)1505167191 
035 |a (DE-576)435167197 
035 |a (DE-599)BSZ435167197 
035 |a (OCoLC)1340701186 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL)  |b a trial of the European Working Group for Adult ALL (EWALL-PH-02)  |c Oliver G. Ottmann, Heike Pfeifer, Jean-Michel Cayuela, Karsten Spiekermann, Joachim Beck, Wolfram E Jung, Andreas Viardot, Schäfer-Eckart Kerstin, Albrecht Reichle, Sébastien Maury, Norbert Schmitz, Daniela Heidenreich, Jens Panse, Christian Junghanß, Emmanuel Raffoux, Felipe Suarez, Gäelle Guillerm, Magda Alexis, Severine Lissandre, Françoise Huguet, Françoise Isnard, Stephane Lepretre, Martine Escoffre-Barbe, Josep-Maria Ribera, Nicola Goekbuget, Herve Dombret, Dieter Hoelzer, Philippe Rousselot 
264 1 |c 2014 
300 |a 1 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.07.2015 
655 7 |a Konferenzschrift  |0 (DE-588)1071861417  |0 (DE-627)826484824  |0 (DE-576)433375485  |2 gnd-content 
700 1 |a Ottmann, Oliver G.  |0 (DE-588)1073558401  |0 (DE-627)829169059  |0 (DE-576)435167081  |4 oth 
700 1 |a Heidenreich, Daniela  |d 1976-  |0 (DE-588)124462073  |0 (DE-627)36336479X  |0 (DE-576)294183248  |4 oth 
773 0 8 |i In  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 124(2014,21) Artikel-Nr. 76104, 1 S.  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL) a trial of the European Working Group for Adult ALL (EWALL-PH-02) 
773 1 8 |g volume:124  |g year:2014  |g number:21  |g extent:1  |a 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL) a trial of the European Working Group for Adult ALL (EWALL-PH-02) 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0006497119697375  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20150707 
993 |a ConferencePaper 
994 |a 2014 
998 |g 124462073  |a Heidenreich, Daniela  |m 124462073:Heidenreich, Daniela  |d 60000  |d 61200  |e 60000PH124462073  |e 61200PH124462073  |k 0/60000/  |k 1/60000/61200/  |p 12 
999 |a KXP-PPN1505167191  |e 2848321555 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"relHost":[{"recId":"266886647","titleAlt":[{"title":"Blood online"}],"pubHistory":["1.1946 -"],"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"American Society of Hematology","role":"isb"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisher":"American Society of Hematology ; Saunders ; HighWire Press","dateIssuedDisp":"1946-","dateIssuedKey":"1946","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif."}],"part":{"extent":"1","year":"2014","text":"124(2014,21) Artikel-Nr. 76104, 1 S.","issue":"21","volume":"124"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"journal of the American Society of Hematology","title":"Blood","title_sort":"Blood"}],"id":{"eki":["266886647"],"zdb":["1468538-3"],"issn":["1528-0020"]},"disp":"798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL) a trial of the European Working Group for Adult ALL (EWALL-PH-02)Blood","note":["Gesehen am 21.04.2023"]}],"person":[{"family":"Ottmann","given":"Oliver G.","display":"Ottmann, Oliver G.","role":"oth"},{"role":"oth","display":"Heidenreich, Daniela","given":"Daniela","family":"Heidenreich"}],"name":{"displayForm":["Oliver G. Ottmann, Heike Pfeifer, Jean-Michel Cayuela, Karsten Spiekermann, Joachim Beck, Wolfram E Jung, Andreas Viardot, Schäfer-Eckart Kerstin, Albrecht Reichle, Sébastien Maury, Norbert Schmitz, Daniela Heidenreich, Jens Panse, Christian Junghanß, Emmanuel Raffoux, Felipe Suarez, Gäelle Guillerm, Magda Alexis, Severine Lissandre, Françoise Huguet, Françoise Isnard, Stephane Lepretre, Martine Escoffre-Barbe, Josep-Maria Ribera, Nicola Goekbuget, Herve Dombret, Dieter Hoelzer, Philippe Rousselot"]},"physDesc":[{"extent":"1 S."}],"note":["Gesehen am 07.07.2015"],"recId":"1505167191","id":{"eki":["1505167191"]},"title":[{"subtitle":"a trial of the European Working Group for Adult ALL (EWALL-PH-02)","title_sort":"798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL)","title":"798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL)"}]} 
SRT |a 798NILOTIN2014